Patents Assigned to Viatris Inc.
  • Methods of using meloxicam for pain treatment and management
    Patent number: 12697341
    Abstract: The present invention relates to a method for managing pain, such as acute pain, post-operative pain, or post-procedure pain, by administering meloxicam.
    Type: Grant
    Filed: November 21, 2025
    Date of Patent: August 4, 2026
    Assignee: Viatris Inc.
    Inventors: Susanne Vogt, Jeffrey P. Smith, Kathleen Ocasio, Joachim Maus, Kristina Marschall, Matthew Hummel, Scott Haughie, Abhijit Deshmukh, Amit Antarkar
  • Transdermal Systems having low dose estrogen and methods of making and use
    Publication number: 20240358655
    Abstract: A transdermal system for providing estrogen to a patient in need thereof is provided. The transdermal system comprises a backing, and a matrix contacting the backing, the matrix configured to release about 4 meg per day to about 36 meg per day of an estrogen to the patient. This application also provides methods of providing estrogen to a patient in need thereof. The methods described in this application comprise applying to the skin of the patient a transdermal system comprising a backing, and a matrix contacting the backing, the matrix configured to release about 4 meg per day to about 36 meg per day of an estrogen to the patient.
    Type: Application
    Filed: March 30, 2022
    Publication date: October 31, 2024
    Applicant: Viatris Inc.
    Inventors: David P. Kanios, Gaurav Tolia